Re: Oncological and Quality-of-Life Outcomes following Focal Irreversible Electroporation as Primary Treatment for Localised Prostate Cancer: A Biopsy-Monitored Prospective Cohort.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Urology"
DOI: 10.1097/01.ju.0000614896.40156.e4
Abstract: available at http://www.ncbi.nlm.nih.gov/pubmed/31103721 Editorial Comment: There is increasing interest in focal ablative therapy as a means of treating unifocal or limited focality early stage prostate cancer. Improved imaging and biopsy techniques have allowed intraprostatic localization… read more here.
Keywords: prostate cancer; irreversible electroporation; focal irreversible; prostate ... See more keywords
Focal irreversible electroporation as primary treatment for localized prostate cancer
Sign Up to like & getrecommendations! Published in 2018 at "BJU International"
DOI: 10.1111/bju.13983
Abstract: To determine the safety, quality of life (QoL) and short‐term oncological outcomes of primary focal irreversible electroporation (IRE) for the treatment of localized prostate cancer (PCa), and to identify potential risk factors for oncological failure. read more here.
Keywords: irreversible electroporation; treatment localized; prostate cancer; focal irreversible ... See more keywords
Median 5-year outcomes of primary focal irreversible electroporation for localised prostate cancer.
Sign Up to like & getrecommendations! Published in 2022 at "BJU international"
DOI: 10.1111/bju.15946
Abstract: OBJECTIVES To evaluate longer-term oncological and functional outcomes of focal irreversible electroporation (IRE) as primary treatment for localised clinically significant prostate cancer (csPCa) at a median follow-up of 5 years (up to 10 years). PATIENTS AND METHODS… read more here.
Keywords: prostate cancer; focal irreversible; irreversible electroporation; term ... See more keywords